Insight Biotechnology search:

<<First <Prev Next> Last>>

Search Results for:
Catalogue No	Partner	Description	Species	Application
HY-R01262-5nmol	MedChemexpress LLC	hsa-miR-4689 mimic		Cancer-programmed cell death
HY-R01263A-20nmol	MedChemexpress LLC	hsa-miR-4690-3p agomir
HY-R01263A-5nmol	MedChemexpress LLC	hsa-miR-4690-3p agomir
HY-RI01263A-20nmol	MedChemexpress LLC	hsa-miR-4690-3p antagomir
HY-RI01263A-5nmol	MedChemexpress LLC	hsa-miR-4690-3p antagomir
HY-RI01263-20nmol	MedChemexpress LLC	hsa-miR-4690-3p inhibitor
HY-RI01263-5nmol	MedChemexpress LLC	hsa-miR-4690-3p inhibitor
HY-R01263-20nmol	MedChemexpress LLC	hsa-miR-4690-3p mimic		Cancer-programmed cell death
HY-R01263-5nmol	MedChemexpress LLC	hsa-miR-4690-3p mimic		Cancer-programmed cell death
HY-R01264A-20nmol	MedChemexpress LLC	hsa-miR-4690-5p agomir
HY-R01264A-5nmol	MedChemexpress LLC	hsa-miR-4690-5p agomir
HY-RI01264A-20nmol	MedChemexpress LLC	hsa-miR-4690-5p antagomir
HY-RI01264A-5nmol	MedChemexpress LLC	hsa-miR-4690-5p antagomir
HY-RI01264-20nmol	MedChemexpress LLC	hsa-miR-4690-5p inhibitor
HY-RI01264-5nmol	MedChemexpress LLC	hsa-miR-4690-5p inhibitor
HY-R01264-20nmol	MedChemexpress LLC	hsa-miR-4690-5p mimic		Cancer-programmed cell death
HY-R01264-5nmol	MedChemexpress LLC	hsa-miR-4690-5p mimic		Cancer-programmed cell death
HY-R01265A-20nmol	MedChemexpress LLC	hsa-miR-4691-3p agomir
HY-R01265A-5nmol	MedChemexpress LLC	hsa-miR-4691-3p agomir
HY-RI01265A-20nmol	MedChemexpress LLC	hsa-miR-4691-3p antagomir
HY-RI01265A-5nmol	MedChemexpress LLC	hsa-miR-4691-3p antagomir
HY-RI01265-20nmol	MedChemexpress LLC	hsa-miR-4691-3p inhibitor
HY-RI01265-5nmol	MedChemexpress LLC	hsa-miR-4691-3p inhibitor
HY-R01265-20nmol	MedChemexpress LLC	hsa-miR-4691-3p mimic		Cancer-programmed cell death
HY-R01265-5nmol	MedChemexpress LLC	hsa-miR-4691-3p mimic		Cancer-programmed cell death